- 작성자 : ILIAS Biologics
- 작성일 : 20-09-11 17:21
- 조회 : 395회
10 Sep 2020
ILIAS Biologics signs MOU with KBIO Health to improve global competitiveness in exosome therapeutics
On Thursday, Sep 10th, ILIAS Biologics Inc. signed a Memorandum of Understanding (MoU) with New Drug Development Center and Bio Pharmaceuticals Manufacturing Center of Osong Medical Innovation Foundation (KBIO Health).
The MoU is focused on collaboration for commercialization of exosome-based therapeutics. In this context, ILIAS takes charge of development of EXPLOR®, which enables loading of large therapeutic cargo proteins into the lumen of exosomes, KBIO Health is in charge of medicinal efficacy evaluation, analysis, GMP production and support of manufacturing process research to improve global competitiveness in exosome-based therapeutics.
Please find the link below for more information. (Korean)